PLX Award Disclosure
Bar-shalev Amos · SEC Form 4 · Filed Sep 4, 2026
Award
Calculated transaction value
$0
Bar-shalev Amos Director
PLX
Transaction date
Sep 3, 2026
Public filing date
Sep 4, 2026
Filing lag
Filed 1 day later
PLX daily price context
Close on/before transaction
$2.62
Sep 3, 2026
Close before public filing
$2.62
Sep 3, 2026
Return since public filing
+2.86%
Through Sep 15, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Restricted Stock Units on Common Stock
- Quantity / price
- 8,500 shares @ $0
- SEC ownership
- Direct
- Transaction code
- A
- Form
- 4
- Filing identifier
- 0001385113-26-000002
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Protalix Biotherapeutics, Inc. PLX | Award | Sep 3, 2026 | $0 |
| Protalix Biotherapeutics, Inc. PLX Current | Award | Sep 3, 2026 | $0 |